340B Drug Pricing Program
Ensuring the Protection of the Vital 340B Program for Patients and Providers
Once again, the Pharmaceutical Research and Manufacturers of America (PhRMA) has demonstrated its willingness to put the profits of its drug company members over the needs of America’s patients.
AHA Statement before the House Committee on Energy and Commerce Subcommittee on Health regarding Lowering Unaffordable Costs: Examining Transparency and Competition in Health Care.
Deceptively branded as an effort to save the 340B program, a legislative campaign by the Pharmaceutical Research and Manufacturers of America, National Association of Community Health Centers and other groups to remove many hospitals, eligible drugs and patients from the 340B program “would only…
Deceptively branded as an effort to save the 340B program, a legislative campaign by the Pharmaceutical Research and Manufacturers of America, National Association of Community Health Centers and other groups to remove many hospitals, eligible drugs and patients from the 340B program “would only…
Hospital and pharmacist advocates for safety-net health care and affordable prescription drugs are united in their firm opposition to a misguided effort by the drug industry and some community health centers that would restrict access to the 340B drug pricing program.
The AHA will continue to fight to protect the 340B program and the patients it benefits against unfounded attacks by big drug companies.
AHA slams group’s proposal that would hurt 340B Program
The AHA today responded to a new group that includes the Pharmaceutical Research and Manufacturers of America, National Association of Community Health Centers and other organizations calling for legislative changes that would hurt the 340B…
Costly innovative cancer treatments and technologies, organizational alignments and shifting sites of care are changing the way care is delivered.
Following the recent district court decision to remand to the Department of Health and Human Services the question of how to repay 340B hospitals for funds unlawfully withheld for five years, AHA today asked to meet with the responsible HHS team to discuss its forthcoming remedial proposal.